{
    "nct_id": "NCT04517643",
    "official_title": "Feasibility of a Personalized Dosimetry-based Treatment Planning for Radioembolization in the Treatment of Unresectable Colorectal Metastases in Liver",
    "inclusion_criteria": "* The Diagnosis of metastatic colorectal cancer to the liver\n* Patients with a diagnosis of metastatic colorectal cancer to the liver\n* Liver metastases are unresectable\n* Tumors are hypervascular based on visual estimation by the Investigator\n* Target tumors are measurable using standard imaging techniques\n* Performance Status Score 0 - 2\n* Age ≥18 years\n* Life expectancy ≥3 months\n* >4 weeks since prior radiation, surgery or chemotherapy\n* Able to comprehend and provide written informed consent in accordance with institutional and federal guidelines\n* At least one month has elapsed since most recent prior cancer therapy with the following exception:\n* Patient is willing to participate in the study and has signed the study informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "Patients may not be treated with TheraSphere® if patients have any of the following exclusions:\n\n* Any pre-treatment laboratory findings within 15 days of treatment demonstrating liver dysfunction:\n* Blood test result levels outside of the normal range\n* Any history of hepatic encephalopathy\n* Any contraindications to angiography and hepatic artery catheterization such as:\n* History of severe allergy or intolerance to any contrast media, narcotics, sedatives or atropine that cannot be corrected or premedicated\n* Bleeding diathesis, not correctable by usual forms of therapy\n* Severe peripheral vascular disease that would preclude catheterization.\n* Evidence of pulmonary insufficiency\n* Significant extrahepatic disease representing an imminent life-threatening outcome\n* Active uncontrolled infection\n* Significant underlying medical or psychiatric illness\n* Co-morbid disease or condition that would preclude safe delivery of TheraSphere® treatment or, in the judgment of the physician, place the patient at undue risk\n* Pregnancy\n* Special Categories of Patients: Not applicable\n* Research in Mentally Disabled People: No. All participants or legal guardians will be fully able to give informed consent.",
    "miscellaneous_criteria": ""
}